ERN2 Antibody

What is ERN2 and why is it important for research?

ERN2 (also known as IRE1β) is a paralogue of the evolutionarily conserved endoplasmic reticulum stress sensor ERN1/IRE1α. Unlike ERN1, ERN2 is uniquely expressed in epithelial cells lining mucosal surfaces of the gastrointestinal and respiratory tracts. It functions distinctly from ERN1, exhibiting weaker endonuclease activity, responding marginally to ER stress stimuli, and acting as a dominant-negative suppressor of stress-induced ERN1 signaling .

ERN2 is critical for:

• Mucin biosynthesis and goblet cell maturation

• Prevention of ER stress in secretory cells

• Host-microbe interactions at mucosal surfaces

• Maintaining epithelial barrier integrity

What types of ERN2 antibodies are available for research purposes?

Table 1: Types of ERN2 Antibodies

Researchers should select antibodies based on experimental needs, with considerations for specificity, sensitivity, and validated applications .

Which tissues and cell lines are recommended for ERN2 antibody validation?

Based on the available data, the following samples are recommended for ERN2 antibody validation:

• Cell lines: JAR cells and A549 cells show positive WB detection

• Tissues: Human liver cancer tissue (for IHC) , mouse stomach tissue lysates

• Primary cells: Goblet cells from gastrointestinal and respiratory tracts

When validating a new ERN2 antibody, include both positive controls (tissues known to express ERN2) and negative controls (tissues from ERN2 knockout models) where possible .

What are the recommended dilutions and conditions for ERN2 antibody applications?

Table 2: Recommended Dilutions for ERN2 Antibody Applications

Remember that optimal conditions are sample-dependent, and it is recommended to titrate the antibody in each testing system to obtain optimal results .

How can I distinguish between ERN1 and ERN2 in my experimental system?

Despite sharing sequence homology, ERN1 and ERN2 have distinct functions. To distinguish between them:

• Antibody selection: Use antibodies that target non-conserved regions to minimize cross-reactivity

• Expression pattern analysis: ERN1 is ubiquitously expressed, while ERN2 is restricted to epithelial cells of mucosal surfaces

• Functional assays:

  • ERN2 has weaker endonuclease activity compared to ERN1

  • ERN2 responds minimally to ER stress inducers that activate ERN1

  • ERN2 can act as a dominant-negative regulator of ERN1 signaling

• Knockout validation: Compare results from ERN1-/- and ERN2-/- models to confirm specificity

Research indicates that ERN2 functions cannot be considered redundant to ERN1, as defects in goblet cell numbers and mucin biosynthesis found in ERN2-/- mice cannot be rescued by ERN1 .

What methodological considerations should be taken when studying ERN2 in the context of host-microbe interactions?

When investigating ERN2's role in host-microbe interactions, consider:

• Germ-free vs. conventionally raised models: Studies show significant differences in ERN2 function between germ-free and conventionally raised animals

• Chemical chaperone treatments: TUDCA (tauroursodeoxycholic acid) treatment can modulate ER stress and affect ERN2-dependent goblet cell maturation in response to gut microbes

• Colonization experiments: ERN2 is required for the maturation of goblet cells in response to microbiota colonization

• Tissue-specific analyses: Focus on epithelial-specific responses rather than whole-tissue analyses to avoid dilution of ERN2-specific signals

• Temporal dynamics: Include time-course experiments to capture the dynamic nature of ERN2 responses to microbial colonization

Research demonstrates that ERN2 is essential for expanding ER and secretory compartment function to prevent ER stress accumulation during host-microbe interactions .

How can I address potential discrepancies in ERN2 antibody detection across different structural prediction methods?

Research on antibody structural prediction shows systematic shifts in surface descriptor distributions depending on the structure prediction method used, which can affect antibody performance . To address this:

• Validate across multiple structure prediction methods: Weak correlations of surface descriptors occur across different structure prediction models

• Employ conformational averaging: Average descriptor values over conformational distributions from molecular dynamics to mitigate systematic shifts

• Consider CDR loop dynamics: The complementarity-determining region loops undergo continuous transitions between conformational states, influencing structural and developability properties

• Establish multiple detection methods: Validate findings using orthogonal approaches (WB, IHC, IF, etc.)

• Implement in silico developability risk flags: Six risk flags have been proposed to predict potential issues in antibody development

For optimal reproducibility, document the structure prediction method used when reporting ERN2 antibody binding characteristics .

What experimental design considerations are important when studying ERN2's role in mucin biosynthesis?

When investigating ERN2's role in mucin biosynthesis:

• Tissue selection: Focus on tissues with high goblet cell content (colon, nasopharynx, etc.)

• Stress induction protocols: Select appropriate ER stress inducers, noting that ERN2 responses differ from ERN1

• Downstream markers: Monitor XBP1 splicing, AGR2 expression, and SPDEF levels, as ERN2 expression highly correlates with these factors

• Histological analyses: Include PAS and MUC5B staining to assess mucus production

• Challenge models: Consider ovalbumin (OVA) challenge in allergic airway inflammation models to reveal ERN2-specific mucus phenotypes

• Parallel analysis: Compare ERN1 and ERN2 pathways simultaneously to distinguish their contributions

Research shows that ERN2-/- mice exhibit decreased mucus cell content and goblet cell numbers in the nasopharynx, with reduced mucus production upon OVA challenge despite normal IL13 levels and eosinophilic cell counts .

What are the most effective protocols for optimizing Western blot detection of ERN2?

For optimal Western blot detection of ERN2:

• Lysate preparation:

  • Use appropriate lysis buffers containing protease inhibitors

  • Include phosphatase inhibitors when studying phosphorylation states

  • Load adequate protein (≥35μg/lane for tissue lysates)

• Gel selection and transfer:

  • Use 7-8% gels for optimal resolution of the 102 kDa ERN2 protein

  • Transfer to PVDF membranes for best signal retention

• Antibody incubation:

  • Use dilutions between 1:500-1:3000

  • Incubate overnight at 4°C for primary antibody

  • Consider milk vs. BSA for blocking based on phospho-specificity

• Detection system:

  • Use high-sensitivity ECL substrate for low-abundance ERN2

  • Consider fluorescent secondary antibodies for quantitative analysis

• Controls:

  • Include positive controls (JAR cells, A549 cells)

  • Use tissue from ERN2-/- mice as negative controls

How can I validate the specificity of my ERN2 antibody?

To validate ERN2 antibody specificity:

• Genetic approaches:

  • Test in ERN2 knockout or knockdown models

  • Use overexpression systems with tagged ERN2

• Peptide competition assays:

  • Pre-incubate antibody with immunizing peptide

  • Observe elimination of specific signal

• Cross-reactivity testing:

  • Test against ERN1 to ensure no cross-reactivity

  • Examine tissues known to lack ERN2 expression

• Multiple antibody validation:

  • Compare results from antibodies targeting different ERN2 epitopes

  • Correlate results across different applications (WB, IHC, IF)

• Mass spectrometry confirmation:

  • Perform immunoprecipitation followed by mass spectrometry

  • Confirm ERN2 identity in pulled-down samples

What considerations should be taken when designing immunohistochemistry experiments for ERN2 detection?

For effective IHC detection of ERN2:

• Tissue preparation:

  • Optimal fixation: 10% neutral buffered formalin for 24-48 hours

  • Paraffin embedding and thin sectioning (3-5 μm)

• Antigen retrieval:

  • Primary recommendation: TE buffer pH 9.0

  • Alternative: citrate buffer pH 6.0

  • Heat-induced epitope retrieval methods yield best results

• Antibody selection and dilution:

  • Recommended dilution range: 1:50-1:500

  • Consider tissue-specific optimization

• Detection system:

  • Polymer-based detection systems provide enhanced sensitivity

  • DAB substrate recommended for visualization

• Controls and counterstaining:

  • Include liver cancer tissue as a positive control

  • Hematoxylin counterstaining for cellular context

  • Include isotype controls to assess non-specific binding

How does ERN2 function differ from ERN1 in cellular physiology?

Despite structural similarities, ERN2 and ERN1 exhibit distinct functional characteristics:

ERN2 acts as a dominant-negative suppressor of stress-induced ERN1 signaling, suggesting it has evolved as a specialized regulator of epithelial ER homeostasis rather than a redundant component .

What is the significance of ERN2 in goblet cell function and mucin biosynthesis?

ERN2 plays critical roles in goblet cell biology:

• Goblet cell maturation: ERN2 is required for goblet cell maturation in response to gut microbes

• Mucin biosynthesis pathway:

  • ERN2 activates XBP1 splicing through its endonuclease activity

  • Spliced XBP1 regulates AGR2, a gene required for mucin biosynthesis

  • ERN2 expression correlates highly with AGR2 and the goblet cell transcription factor SPDEF

• ER homeostasis:

  • Prevents ER stress accumulation during high secretory demands

  • Expands ER and secretory compartment function

• Pathophysiological implications:

  • ERN2-/- mice show decreased mucus cell content and goblet cell numbers

  • When challenged with ovalbumin, ERN2-/- mice exhibit reduced mucus production despite normal IL13 levels and eosinophilic cell counts

  • Defects in ERN2 may contribute to mucosal barrier dysfunction in inflammatory diseases

How can ERN2 antibodies be utilized in studying host-environment interactions at mucosal surfaces?

ERN2 antibodies can be leveraged to investigate host-environment interactions through:

• Comparative expression analysis:

  • Map ERN2 expression across different mucosal surfaces

  • Compare germ-free versus conventionally raised animals

  • Monitor changes during microbial colonization

• Cell-type specific responses:

  • Identify ERN2-expressing cells during host-microbe interactions

  • Track goblet cell differentiation and maturation

  • Co-localize with mucin production and secretion

• Signaling pathway dissection:

  • Monitor ERN2 activation in response to microbial stimuli

  • Assess downstream targets like XBP1 splicing and AGR2 expression

  • Compare with classical ER stress pathways

• Therapeutic intervention assessment:

  • Evaluate effects of chemical chaperones like TUDCA on ERN2 function

  • Test mucosal protective agents for effects on ERN2 signaling

  • Monitor ERN2 in response to probiotics or prebiotics

Research has demonstrated that ERN2 enables host adaptation to microbiota by promoting mucus production, representing a critical link between environmental sensing and mucosal homeostasis .

What are the emerging research directions for ERN2 antibodies in disease models?

Several promising research directions for ERN2 antibodies include:

• Inflammatory bowel diseases:

  • Investigate ERN2 expression and function in IBD patient samples

  • Assess correlations between ERN2 levels and disease severity

  • Explore therapeutic targeting of the ERN2 pathway

• Respiratory diseases:

  • Study ERN2 in asthma, COPD, and cystic fibrosis models

  • Examine ERN2's role in mucus hyperproduction and airway obstruction

  • Correlate ERN2 dysfunction with respiratory epithelial barrier integrity

• Cancer research:

  • Explore ERN2 expression in epithelial cancers

  • Investigate IHC detection in liver cancer tissue

  • Assess ERN2's potential as a diagnostic marker or therapeutic target

• Drug development:

  • Utilize ERN2 antibodies to screen compound libraries

  • Identify small molecules that modulate ERN2 activity

  • Develop targeted therapies for ERN2-associated pathologies

• Microbiome interactions:

  • Study how different microbial communities affect ERN2 expression

  • Investigate ERN2's role in maintaining host-microbe mutualism

  • Explore probiotic interventions that normalize ERN2 function